Related by context. All words. (Click for frequent words.) 62 risks 59 risksassociated 53 inherent risks 53 contingent guaranties 51 risks associatedwith 50 uncertainties inherent 48 inherent uncertainty 48 uncertainties 48 regarding Heska 47 Bioaccelerate compounds under 47 obtaining regulatory approvals 46 adverse effects 46 fluctuations 46 viii 46 risksand uncertainties 46 OneBeacon filings 46 xvii 46 risks anduncertainties 45 xviii 45 xiii 45 xxv 45 xxi 45 vii 44 otherrisks 44 general economicconditions 44 theimpact 44 market fluctuations investee 44 ADSI reliance 44 Equinix filings 44 changesin 44 Thalomid R 44 therisk 43 relatedto 43 adversely affect Univest Corporation 43 Shire plc Attention Deficit 43 Bioenvision dependence 43 limitedto 43 TranSwitch indebtedness 43 xix 43 ourproducts 43 TranSwitch filings 43 xii 43 xvi 43 affecting Amarin 43 unanticipated geological 43 ARLP Partnership 43 entails inherent 43 otherfactors 42 productsand services 42 successfully integrate 42 withrespect 42 Avivo Corporation 42 impactof 42 Bioenvision compounds under 42 Bioenvision filings 42 without limitation 42 pricing pressures 42 anduncertainties 42 vi 42 Risks 42 economicconditions 42 associated 42 VELCADE therapy 42 fighter jets del Rosario 42 unanticipated difficulties 42 risk 42 risks associated therewith 42 inherent 42 Teva Annual Report 42 Immtech clinical trials 42 Waratah Coal filings 42 depression cyberbullying sexting 42 materially adversely affect 41 e# periodic 41 postretirement benefit obligations 41 Shire Attention Deficit 41 adverse 41 xxviii 41 BOPET film industry 41 adversely affect 41 OSI Pharmaceuticals filings 41 thepossibility 41 Flamel Annual Report 41 ix 41 Pure Biofuels ability 41 calcium hypochlorite markets 41 bulk amorphous alloys 41 dangers 41 xxii 41 HealthGate ability 41 OPAXIO pixantrone 41 SAN FRANCISCO Narin Leininger 41 liabilities slippage 41 suchforward looking 41 notlimited 41 associatedwith 41 incur unanticipated 41 economically recoverable coal 41 cyclical nature 41 InSite Vision filings 40 currency fluctuation 40 orotherwise 40 acquisitions dispositions 40 requirements xxii 40 xv 40 SeraCare competitors 40 Company periodic filings 40 Excluding acquisitions divestitures 40 technological developments 40 Immtech scientists 40 xxvii 40 filingswith 40 Form 8K #K 40 party VLSI fabrication 40 Crisa acquisition 40 novel therapeutic modality 40 ourability 40 fluctuations cyclicality 40 concerning Alexza 40 unitholder liability 40 taking Gleevec tablets 40 DSL.net s 40 legal proceedings xxi 40 consolidations restructurings bankruptcies 40 Silver Wheaton purchases 40 tenant bankruptcies 40 iv 40 governmental approvals 40 theSecurities 39 AspenTech periodic reports 39 without limitation Terremark 39 affirmative covenants 39 uncertaintiesthat 39 QSound periodic reports 39 Novavax filings 39 involve risks anduncertainties 39 SciClone filings 39 ability tosuccessfully 39 PLIVA acquisition 39 odds Lutkus 39 EpiCept periodic reports 39 PharMerica LTC Transaction 39 Nymox filings 39 Unitholder liability 39 viii inability 39 SemGroup LP SemGroup 39 Zi OEM 39 deploy MDCE services 39 Alnylam dependence 39 men bisexuals transgender 39 currency fluctuations imprecision 39 xxvi 39 commercialize ZYFLO CR 39 cadence regulatory approvals 39 differ materially 39 Omtool periodic reports 39 affecting IsoTis 39 dimesylate Attention Deficit 39 downsides 39 HANA MAX 39 hazards 39 Neoware periodic 39 multiple lease terminations 39 necessary regulatory approvals 39 consummating acquisitions 39 Cytogen dependence 39 arenot limited 39 Jupiterimages respective 39 adversely affect FNB 39 Atheros Quarterly Report 39 Enpath ability 39 nonoccurrence 39 risks uncertainties 39 BigBand periodic 39 Optimer filings 38 dependence 38 inherently risky 38 Favrille filings 38 aresubject 38 xiv 38 challenges Liu Shaowu 38 PLAVIX R patent 38 perinatal complications 38 andgeneral 38 forex futures 38 CFRA forensic accounting 38 worsening peripheral neuropathy 38 orother 38 mu opioid agonists 38 further reassort 38 xxiii 38 Questcor intellectual property 38 theforward looking 38 relative illiquidity 38 consequences 38 pulls Darvon painkiller 38 HIV serostatus 38 vii IBC 38 Secure Computing periodic 38 Micromet Annual Report 38 5 lipoxygenase inhibitor 38 Acticoat TM products 38 integrate restructurings consolidations 38 didanosine associated 38 statements arebased 38 Hifn filings 38 uninsurable risks 38 iii 38 involve risksand uncertainties 38 Spelling follows North 38 Freedom2 Holdings Inc. 38 borrower depositor 38 Shinji Kinjo spokesman 38 c SIGA 38 FierceGovernmentIT tracks 38 PDI periodic filings 38 TRISENOX ® 38 theseforward looking 38 GenVec filings 38 sepsis infection Notaros 38 AudioCodes filings 38 diminishing quantities 38 currency fluctuations 38 hoFH 38 unanticipated 38 Yucheng filings 38 substantial indebtedness 38 BiDil XR drug 38 devices GlobeXplorer distributes 38 Chaim Lebovits President 38 Variable annuities involve 38 MyVax ® 38 Telesat Telesat leverage 38 constructing IBX centers 38 forwardlooking statements 38 Heska reliance 38 Erythropoietic therapies may 38 RR Donnelley periodic filings 38 BioGold Fuels 38 bioMETRX filings 38 nonhematologic adverse reactions 38 Liquor Stores LP 38 tuberculosis strep throat 37 Atheros Annual Report 37 Theseforward looking 37 radiotherapy radiosurgery proton therapy 37 Varian Semiconductor dependence 37 VYVANSE TM lisdexamfetamine 37 Rami Efrati CEO 37 DES silicone 37 adversely affect Waste Connections 37 heading RISK FACTORS 37 Lexiscan R 37 Therein lurks 37 xi 37 title taxation sociopolitical 37 SMNA attempts 37 regulatory approvals 37 TFC receivables 37 causeactual results 37 suitablef 37 thereby negatively impacting 37 Regional today provides 37 indebtedness covenant 37 established CoverX R 37 HTA periodic 37 differmaterially 37 LDK Solar filings 37 adversely affecting Cubist 37 histrelin manufacturing marketing 37 ultimate recoverability 37 xxiii fluctuations 37 Prospectuses contain 37 heading ITEM 1A 37 abnormal genital 37 Shire plc filings 37 lender consents 37 Quantum periodic filings 37 harmful effects 37 vii Cubist ability 37 Vion Annual Report 37 Matav Cable 37 signal averaging electrocardiography 37 Narrowly focused 37 FuelQuest solutions 37 ExchangeCommission 37 pathologists oncologists hospitals 37 unfairly interferes 37 securityholder approvals 37 website www.FreePennyAlerts.com 37 statementsregarding 37 expenses associated therewith 37 hematopoietic malignancies 37 containing abacavir 37 Laurion cautions against 37 Sirna concentration 37 BioSante licensees 37 successfully commercialize Silenor 37 EGRIFTA TM 37 Somaxon ability 37 Biogold Fuels 37 Terax Annual Report 37 Comment Ratings 37 should consult NeurogesX 37 theavailability 37 Daytrana TM 37 variability 37 Avoid processed foods 37 website www.PennyStockAlley.com 37 orofacial clefts 37 unfavorably impacted 37 xii fluctuating currency 37 LinuxLink reduces 37 cancellations rescheduling 37 redundancy scalability 37 adverse determinations 37 Dr.S.Sivaraman shall 37 requisite stockholder 37 BioMarin filings 37 uncertainties impacting Sirit 37 n h r 37 thebenefits 37 andnon 37 website GreenGainers 37 xxiv 37 NxStage filings 37 bacterial parasitic 37 implications 37 Acorda Therapeutics filings 37 Securities andExchange Commission 37 TP# CETi 1 37 perils 37 Biophan periodic filings 37 xxvi introduction 37 containing LABAs 37 pigment alters 36 involverisks 36 GulfMark filings 36 properties ultimate recoverability 36 VanceInfo filings 36 APDN SEC 36 suchstatements 36 beaded fringed belt 36 indexation clauses 36 rheumatoid arthritis thrombocytopenia 36 Marani Brands filings 36 rapid technological 36 insects mites 36 looking statementsare 36 Nephros Annual Report 36 measurement units 36 Including newbuildings 36 interpreting geological 36 Terremark filings 36 ourbusiness 36 sNDAs 36 Risk Disclosure Trading 36 stroke hypertension palpitations 36 Lance Locurto 36 xi fluctuating currency 36 Vion filings 36 TNF blocker therapy 36 counterparty creditworthiness 36 differ materiallyfrom 36 infants Sundlof 36 tantalum lithium tin 36 theinformation 36 caption Risk Factors 36 TeamStaff filings 36 effects 36 Candente relies upon 36 fungal infections malaria tuberculosis 36 Micromet Quarterly Report 36 Antidepressant medications benefit 36 forodesine hydrochloride BCX 36 undetected errors 36 Valentis Annual Report 36 Aspyra actual 36 vary materially 36 related thereto 36 regulatory authorizations 36 operated bakery cafe 36 caption Factors 36 XP# XP# 36 AMPYRA ® dalfampridine 36 customers licensees licensors 36 impacts 36 hold E Hedger 36 naturally occurring toxins 36 unattended SRX 36 surgical cryoablation 36 Risk Disclosure 36 EMPOWER pivotal trial 36 ARCADIS filings 36 commercially mineable 36 arebased 36 SecureTransport enables 36 bone marrow fibrosis 36 Phase III LibiGel 36 xiii fluctuating currency 36 nucleoside analogues alone 36 geology continuity 36 Familiarize yourself 36 additional cytogenetic abnormalities 36 CSLR expectations regarding 36 disinterested Shareholder approval 36 CHDT SEC Filings 36 Markland Technologies filings 36 andfinancial 36 ImmunoGen Annual Report 36 complexities 36 botulin based 36 ePort devices 36 cause actual 36 marketconditions 36 periodic redeterminations 36 FRAGMIN R 36 site www.buyins.net 36 incurrence 36 impacton 36 systemic immunosuppressive drugs 36 materially differ 36 Risk Factors section 36 market PolyHeme commercially 36 inflammatory autoimmune diseases 36 Projects Initiation 36 InSite reliance 36 satellite datacasting market 36 servicemark risks xiii 36 assumptions underlying 36 positive inotropic agents 36 substantially excreted 36 current physiologic opioid 36 unfavorable geologic 36 v Dot VN 36 OrCrude TM process 36 Vitria Annual Report 36 VIOXX Lawsuits 36 hippest contender 36 HealthTronics periodic filings 36 changes Decorize dependence 36 punctal plug 36 unforeseen underperformance 36 Firstgold Corp. s 36 InfoSearch filings 36 early extinguishments 36 Iusacell Celular 36 india viagra 36 Hyperactivity Disorder ADHD 36 dangers posed 36 Daytrana ™ 36 remanufactured rebuilt engines 36 AcryMed technologies 36 Emtriva Viread 36 andbusiness 36 Thalomid ® 36 mergers dispositions 36 relating 36 Ceragon Annual Report 36 3f Therapeutics 36 factors 36 areforward looking 36 Navios Partners filings 36 quintuple kidney transplants 36 CV thrombotic 36 IoGen ™ 36 biotherapeutic drugs 36 concomitant 36 prescription brands RESTYLANE 36 anti arrhythmic medicines 36 NetworkComputing.com cloud computing 36 forodesine HCl 36 EVIZON TM squalamine lactate 36 Always consult 35 unexplained vaginal bleeding 35 reputational risk 35 treatment emergent hyperglycemia 35 PGxPredict tests 35 EGRIFTA ™ 35 iv unanticipated 35 negatively impact 35 evaluating Questcor 35 BOS periodic 35 Mediaseed R 35 antidiabetic medications 35 INTEGRILIN R eptifibatide Injection 35 PURPOSE OF SAFE HARBOR 35 Reminder Webcast Alert 35 Voxware filings 35 section captioned Risk 35 MHG Annual Report 35 growing intertrack 35 torsemide ER 35 concomitant medication 35 deletion 5q cytogenetic abnormality 35 adversely affect NextEra Energy 35 maycause actual results 35 Alprox TD 35 Rexahn licensees 35 ramifications 35 Zemiva TM 35 affecting mortality morbidity 35 currentexpectations 35 Irrevocable Life 35 unfavorable variances 35 Disruptions uncertainty 35 LandStar Inc. s 35 Entereg TM 35 Closely spaced births 35 TGS reliance 35 affect Petroflow 35 severe hepatomegaly 35 ™ testosterone gel 35 Research CECR 35 GEROVA underwrites insurance 35 eTelcharge.com Inc. 35 approve prepackaged bankruptcy 35 Intellon ICs 35 PolyMedix filings 35 Risk Disclosure Document 35 cardiovascular disease hypertension 35 tarmac strandings Hanni 35 website www.gladiatorstocks.com 35 PD2i Analyzer TM 35 Compans 35 Ceragenin ™ technology 35 GnRH antagonists 35 NUCYNTA R 35 candidates Albania Bosnia 35 Nephros filings 35 visit www.ethosfr.com 35 Prelude SkinPrep Systems 35 Cytogen periodic filings 35 stockholder approvals 35 evaluating Zhongpin 35 valuation allowances 35 potency APIs 35 uncertainties materialize Shire plc 35 Allister Hogg Allan Jacobsen 35 impair Lillian Vernon 35 rapid technological advances 35 repopulate CNS 35 gastrointestinal GVHD include 35 STRIANT ® 35 Heavy snorers 35 Prochieve R 35 theability 35 zileuton IV 35 EpiCept filings 35 Filtran Microcircuits Inc. 35 GELV gasification technology 35 Chondrogen 35 RXi Pharmaceutical Corporation 35 acquisitions divestures 35 mergers consolidations 35 asset impairments 35 cardinals donned Delly 35 Emisphere filings 35 peramivir clinical trials 35 ESTRASORB R 35 ManTech Annual Report 35 IGI periodic 35 non selective NSAIDs 35 These statementsare 35 Amylin Lilly 35 Infor expressly disclaims 35 PAINTED POST BARBERSHOPPERS REHEARSAL 35 intra arterial injection 35 LPM TM 35 underlying sulfide mineralization 35 theglobe.com inc 35 seizures injunctions 35 assimilating acquired 35 inventory obsolescence 35 difficulties 35 obesity sedentary lifestyle 35 oral cleft 35 SumTotal Enterprise 35 Sevcon supplies 35 NIH registry www.clinicaltrials.gov 35 SANCTURA SANCTURA XR NEBIDO 35 InStorage Limited 35 nonprescription NSAIDs 35 HandHeld Entertainment filings 35 prolong QT interval 35 SILCRYST TM coatings 35 UniversalPHOLED 35 Shire ADHD 35 intercompany transactions 35 Wilmette Libertyville Bank 35 af fected 35 Hopper costarred 35 Equities Fixed Income 35 Varian Semiconductor reliance 35 Ngai Hing 35 Generx TM 35 potentially hepatotoxic 35 Blowouts onshore Fear 35 antigun trafficking agents 35 counterfeit impure 35 ENABLE Phase 2 35 patented VRB 35 distinguishing MDCE products 35 retain drilling rigs 35 IMPAX filings 35 Medtronic periodic 35 Orbix R 35 reunites Rogen 35 taribavirin 35 caption Risks 35 SAECG software used 35 WDEQ Permit 35 ii Immtech ability 35 GrowthWorks refers 35 payor acceptance 35 persistency mortality 35 camouflage profanity 35 Mesafem 35 productdevelopment 35 OneBeacon Annual Report 35 Rosetta dependence 35 Antisoma fills 35 APTIMA HPV assay 35 caption Management Discussion 35 www.activant.com 35 UFX website 35 Cons Expensive 35 serious cardiovascular thrombotic 35 #-# CONTACTS offers 35 deCODE filings 35 severe renal insufficiency 35 noticeably thinner stark 35 visit www.mmrglobal.com 35 - Effect [002] 35 Baqoubah north 35 generic Copaxone 35 WNS ADS 35 Adolor Reports 35 captions Item 1A 35 uncertainties materializes FICO 35 xv licensing 35 iii Cubist 35 cybertheft cyberfraud cyberwarfare 35 candidate Ramoplanin 35 vii Dynamic 35 renal flare 35 IFS 2C 35 Limited NNL 35 KAPVAY TM 35 By Lisa Eckelbecker 35 department prohibited SanGar 35 addition Exponent evaluates 35 AzaSite TM 35 social networking rolodex 35 Allovectin 7 r 35 Absentee bids shall 35 Retrograde ejaculation 35 CORLUX CORT # 35 beam epitaxy 35 Jyles Tucker midway 35 untreated STDs 35 IVAX Diagnostics filings 35 low TSNA dissolvable 35 website StockMarketLife.com 35 autoimmune reactions 35 successfully integrate Legerity 35 AENY filings 35 hip hop alter ego 35 Assumptions relating 35 andrelated 35 Beta coefficient 35 Plan Disclosure Document 35 history Progression 35 tomaintain 35 inaccurately estimating 35 Easy Forex strongly 35 TrueKnowledge Platform TM 35 Nutritionists warn 35 Suites Fisherman Wharf 35 EGRIFTA 34 uncertainties materialize Shire 34 STRIANT R 34 theuse 34 Emad Darwish director 34 restructurings financings 34 Valcyte tablets 34 Regeneron filings 34 Inverse Floaters 34 promulgated thereunder 34 Partially offset 34 Furthermore ArQule 34 LEVADEX ™ 34 prepayment speeds loan originations 34 delinquencies defaults 34 Nabors participates 34 impacting WesBanco 34 Dyax utilizes 34 ticker symbol AMTD 34 transportation storage terminalling 34 - Effect [009] 34 Pharmacia Monsanto 34 xxxii 34 myopathy rhabdomyolysis 34 SiriCOMM periodic reports 34 Palatin periodic filings 34 PROLOR filings 34 oral clefts 34 cause actual resultsto 34 Acturion GmbH 34 sanofi aventis Novartis 34 Cerashield TM 34 AGGRASTAT R tirofiban hydrochloride 34 By Beth Sneller 34 nasopharyngitis headache 34 capture exosomes 34 opioid bowel dysfunction 34 COPEGUS therapy 34 Adverse effects 34 newproducts 34 Reglan metoclopramide 34 Nektar proprietary 34 Invitel Holdings operates 34 permitting timelines 34 Web site http:/www.EmergingStockReport.com 34 manufacture RISPERDAL CONSTA 34 complexities inherent 34 SURETY LICENSES c 34 collect reinsurance recoverables 34 Accounts Receivable Financing Receivable 34 glioma malignant type 34 PD2i ® algorithm 34 Verena filings 34 Therapeutic Antibodies segment 34 living modified organisms 34 painful rocklike scar tissue 34 tizanidine hydrochloride short 34 dormitory matron sexually assaulted 34 symbol CIMT 34 vaginally administered lidocaine 34 visit www.clicksoftware.com 34 Fampridine SR delays 34 maydiffer materially 34 website www.nyandcompany.com 34 non capitalizable 34 Cialis dosage 34 H#N# virus Scaperotti 34 Gottschalks Annual Report 34 visit www.bioject.com 34 fcmi buying 34 Issuer Bid Circular 34 Amgen Neulasta R 34 failure osmotic nephrosis 34 contract indemnities defects 34 TietoEnator specializes 34 Fabrinet focuses 34 damage cirrhosis liver 34 PVC Additives 34 Invitel Holdings filings 34 joint ventures strategic alliances 34 Pharmion Quarterly Report 34 NOT aligned 34 anaphylaxis dyspnea flushing 34 menopause contraception 34 sexual transmitted infections 34 maycause 34 thispress release 34 viruses fungi 34 significantly tougher comparatives 34 caption Risks Related 34 seasonality 34 affect Pennichuck Corporation 34 hematological disorders 34 HEPLISAV TM hepatitis B 34 Vital Images encourages 34 Narin Leininger knows 34 propoxyphene containing 34 EPRI conducts 34 xviii currency 34 varietyof 34 please visit http:/www.weingarten.com 34 http:/investors.formfactor.com/edgar.cfm 34 - Effect [003] 34 Commissions trailing 34 involve anumber 34 Align periodic 34 NEUMUNE 34 AstraZeneca MedImmune 34 DCVax R Prostate 34 FIDAC serves 34 affecting Pennichuck Corporation 34 Ibis T# TM 34 Educate yourself 34 Orosi Mill project 34 acquisitions divestitures strategic alliances 34 alpha interferons 34 Cautionary Disclosures 34 S. aureus sepsis 34 trojans rootkits worms 34 FARMERS MARKET LOS ANGELES 34 confirmed cancer causers 34 words TRUST WOMEN 34 technological obsolescence 34 containing diphenhydramine brompheniramine 34 using BioSante patented 34 Company nanocrystalline materials 34 Inovio Annual Report 34 Aceon 34 Surfactant Replacement Therapies 34 TSX VENTURE CHQ 34 amlodipine beta blockers 34 GLASSIA 34 London Euronext.Liffe derivatives 34 realizability 34 - Effect [008] 34 Modavox filings 34 randomized metastatic breast 34 GigOptix periodic reports 34 AERx ® 34 uncertainties materialize adversely 34 lifelong immune suppressing 34 proprietary VLP 34 prostate testicular 34 Ben Amrany 34 JLG acquisition 34 Sky Kalkman So 34 overt advertisements 34 e mail lifestyle@readingeagle.com 34 KIACTA TM 34 ADA CS 34 Tucows filings 34 indemnification provisions 34 Westell Annual Report 34 SpaceDev innovations 34 Palatin intends 34 EGFr humanized monoclonal antibody 34 powder infant formulas 34 looking statements 34 Enova Systems periodic filings 34 IBISWorld evaluates 34 Novelis cautions 34 renal dysfunction acute renal 34 GSK Janssen Pharmaceutica 34 workersa compensation 34 #.# #.#.# 34 Develop strategies 34 sublease recoveries 34 CEFF financings subject 34 proprietary capillary aerosolization 34 AGIFM affiliate serves 34 PFICs 34 technological innovations adversely affecting 34 include ClindaReach TM 34 Wavefront Powerwave 34 Verint Systems Inc 34 Introgen filings 34 subsidiary Heilongjiang Lanxi 34 website PennyPic.com 34 genome SNPs conferring 34 ii 34 intraoperative complications 34 SIMPONI TM 34 CECO Annual 34 factional warlord Gulbuddin Hekmatyar 34 anxiety palpitations dizziness 34 KAPVAY ™ 34 disadvantages 34 name Biochronomer TM 34 thepotential 34 AMEX symbol KRY 34 satisfy indemnification obligations 34 offuture 34 thoracic drainage 34 RTGV reports 34 orlistat marketed 34 herpes chlamydia 34 Gammon Gold Annual Report 34 Dot VN filings 34 - Effect [005] 34 CRIXIVAN 34 egX Canada 34 Federal Mogul aftermarket 34 Lipitor Zoloft 34 CTLA4 Ig product 34 Resonator ™ device 34 skateboarding BMX Motocross 34 innovative aerosolization 34 strategic alliances joint ventures 34 Metalink Annual Report 34 couldcause actual results 34 squalamine 34 HF Lenfest member 34 im peramivir 34 inadequately sterilized needles 34 BioForce Nanosciences actual 34 molecular chaperone regulation 34 Eckhart Fleck 34 party payors 34 Dr Muraguri 34 FirstMortgage Inc. 34 transportation fractionation 34 Kawaoka explains 34 genetic susceptibilities 34 IAMGOLD Annual Report 34 variable annuity reinsurance 34 CoTherix logo 34 unduly rely 34 ECD filings 34 SIMOX SOI 34 though Persichini characterized 34 transgenically produced product 34 Ceragon dependence 34 MAb therapy 34 Azedra TM Onalta TM 34 Orthovita filings 34 knee arthroscopies prostate biopsies 34 mitigants 34 methodological weaknesses 34 bladder cervix 34 potent CYP#A# inducer 34 IL# PE 34 vasomotor symptoms associated 34 SMA Indústria Química SA 34 Textainer expectation 34 VIBATIV ™ 34 environmental impacts 34 commercialize Qutenza 34 tamoxifen Nolvadex ® 34 taxation socio 34 undernoted items 34 TRIPS flexibilities 34 e mail bbishop@thedailyreview.com 34 noncash unrealized 34 fatal hemorrhagic 34 minesites 34 chronic metabolic acidosis 34 LOVENOX R 34 research anddevelopment 34 egX 34 involve risks 34 CRUGF 34 antiplatelet therapy prescribed 34 visit http www.cpsc.gov 34 Risk Factors 34 postretirement benefit plans 34 Metabasis dependence 34 implantable glucose sensor 34 superpotent ingredients Saben 34 asides etc. 34 bats skunks raccoons 34 Affymax Quarterly Report 34 referenced investigational 34 HTDS Corporation 34 wv ` 34 Factors influencing 34 CRM Cegedim Dendrite 34 NMJ Radio show 34 TIAs peripheral vascular 34 visit www.BYETTA.com 34 factors influencing 34 affecting ChinaNet 34 · Demonstrated 34 bouncer squirted 34 Yima project 34 applicable Offering Memorandum 34 CompanyaEUR TM s 34 ATRIPLA 34 strategic alliances 34 include Alferon N 34 defects vii 34 cash fl ows 34 targets TRPM8 33 Coadministration 33 x Immtech 33 bespectacled Lavallee Davidson 33 treat chronic sinusitis 33 Nuinsco believes 33 Constant Contact Logo 33 I. Item 1A 33 Easy Forex website 33 Miss CKC 33 MyVax R 33 Premature menopause 33 maximizing ROI 33 necessarily reflect Dawn.com 33 adversely affecting REITs 33 SIMPONI ® 33 xiv licensing 33 trademarks KRL 33 trivial Klatsky 33 Tß4 33 lumiracoxib 33 caffeine taurine 33 CholeraGarde R Peru 33 montgomeryadvertiser.com s 33 HOLDRS SM 33 forward.looking statements 33 concerning VAALCO 33 Activision Publishing maintains 33 HIPAA Gramm Leach Bliley